The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics of patients with metastatic malignant melanoma in Colombia: Results of the Epidemiologic Registry of Malignant Melanoma REMMEC ACHO.
 
Aylen Vanessa Ospina Serrano
Honoraria - AstraZeneca; MSD
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - Roche
 
Juan David Ortiz Diaz
No Relationships to Disclose
 
Fernando Contreras
Honoraria - Amgen; AstraZeneca/Columbia; Bristol-Myers Squibb Colombia; Janssen; Lilly; MSD Oncology; Novartis Colombia
Consulting or Advisory Role - Bristol-Myers Squibb Colombia; GlaxoSmithKline
 
Isabel Munevar
No Relationships to Disclose
 
Paola Jimenez
No Relationships to Disclose
 
William Armando Mantilla
Employment - Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I)
Honoraria - AstraZeneca/Daiichi Sankyo; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Pfizer
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Roche/Genentech (Inst)
 
Henry Idrobo
No Relationships to Disclose
 
Pedro Ramos
No Relationships to Disclose
 
Ray Manneh Kopp
Honoraria - Amgen; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Tecnofarma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche; Sanofi; Tecnofarma
Speakers' Bureau - Asociación Colombiana de Hematoligía y Oncología (ACHO); San Jorge Foundation
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Merck Sharp & Dohme; Novartis; Pfizer
Travel, Accommodations, Expenses - Bayer; Merck Sharp & Dohme; Pfizer; Roche/Genentech
 
Natalia Arango Acevedo
No Relationships to Disclose
 
Daniel Andres Santa
No Relationships to Disclose
 
Giovanna Patricia Rivas Tafurt
Honoraria - BRISTOL MYERS SQUIBB
Travel, Accommodations, Expenses - Roche
 
Alicia Quiroga
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Janssen; MSD Oncology
 
Claudia Vargas
No Relationships to Disclose
 
Andres Yepes
Honoraria - AstraZeneca; Bristol-Myers Squibb (Mexico); Janssen Oncology; Roche
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb (Mexico)
 
Carmen Marcela Alcala Castro
No Relationships to Disclose
 
Mauricio Lema
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Dr. Reddy's Laboratories; Lilly; MSD Oncology; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Medarex; Lilly; MSD Oncology; Pfizer; Roche
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Roche
 
Isabel Chinchia
Honoraria - Amgen; Janssen (I)
Consulting or Advisory Role - Janssen Oncology; Roche
Speakers' Bureau - Amgen
 
July Andrea Russi Noguera
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - MSD; Novartis
 
Ivan Camilo Triana
No Relationships to Disclose